IFNB1 and neoplasm: Translating these findings into in vivo models, vaccination with nECTs leads to a pronounced infiltration of effector T cells into tumor sites, concurrent with an IFN‐β‐mediated remodeling of the suppressive tumor microenvironment by innate immune cells.